These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 32581257)

  • 41. Oxidative metabolism of amprenavir in the human liver. Effect of the CYP3A maturation.
    Tréluyer JM; Bowers G; Cazali N; Sonnier M; Rey E; Pons G; Cresteil T
    Drug Metab Dispos; 2003 Mar; 31(3):275-81. PubMed ID: 12584153
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metabolism and Disposition of Pacritinib (SB1518), an Orally Active Janus Kinase 2 Inhibitor in Preclinical Species and Humans.
    Jayaraman R; Pasha MK; Williams A; Goh KC; Ethirajulu K
    Drug Metab Lett; 2015; 9(1):28-47. PubMed ID: 25600203
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dexamethasone metabolism in vitro: species differences.
    Tomlinson ES; Maggs JL; Park BK; Back DJ
    J Steroid Biochem Mol Biol; 1997 Jul; 62(4):345-52. PubMed ID: 9408089
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Species differences in the formation of vabicaserin carbamoyl glucuronide.
    Tong Z; Chandrasekaran A; DeMaio W; Jordan R; Li H; Moore R; Poola N; Burghart P; Hultin T; Scatina J
    Drug Metab Dispos; 2010 Apr; 38(4):581-90. PubMed ID: 20032194
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In silico modeling for the nonlinear absorption kinetics of UK-343,664: a P-gp and CYP3A4 substrate.
    Abuasal BS; Bolger MB; Walker DK; Kaddoumi A
    Mol Pharm; 2012 Mar; 9(3):492-504. PubMed ID: 22264132
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics, mass balance, and metabolism of [
    He YF; Liu Y; Yu JH; Cheng H; Odilov A; Yang FP; Tian GH; Yao XM; Duan HQ; Yu CY; Yu C; Liu YM; Liu GY; Shen JS; Wang Z; Diao XX
    Acta Pharmacol Sin; 2023 Jan; 44(1):221-233. PubMed ID: 35676531
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Nonclinical Pharmacokinetics and Prediction of Human Pharmacokinetics of SPH3127, a Novel Direct Renin Inhibitor.
    Zhang L; Mao Y; Gao Z; Chen X; Li X; Liu Y; Xia G
    Eur J Drug Metab Pharmacokinet; 2020 Feb; 45(1):15-26. PubMed ID: 31494843
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Validated LC-MS/MS method for the determination of mirodenafil in rat plasma and its application to a comparative pharmacokinetic study of the free base and hydrochloride salt forms of mirodenafil.
    Kim TK; Yoo HH; Park JH
    Arzneimittelforschung; 2012 Jul; 62(7):351-4. PubMed ID: 22692776
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Species differences in stereoselective metabolism of mephenytoin by cytochrome P450 (CYP2C and CYP3A).
    Yasumori T; Chen L; Nagata K; Yamazoe Y; Kato R
    J Pharmacol Exp Ther; 1993 Jan; 264(1):89-94. PubMed ID: 8423554
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metabolism of the trisubstituted purine cyclin-dependent kinase inhibitor seliciclib (R-roscovitine) in vitro and in vivo.
    McClue SJ; Stuart I
    Drug Metab Dispos; 2008 Mar; 36(3):561-70. PubMed ID: 18048486
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of salvianolic acid B and tanshinone IIA on the pharmacokinetics of losartan in rats by regulating the activities and expression of CYP3A4 and CYP2C9.
    Wang R; Zhang H; Wang Y; Yu X; Yuan Y
    J Ethnopharmacol; 2016 Mar; 180():87-96. PubMed ID: 26806573
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Disposition of 1-[3-(aminomethyl)phenyl]-N-[3-fluoro-2'- (methylsulfonyl)-[1,1'-biphenyl]-4-yl]-3-(trifluoromethyl)- 1H-pyrazole-5-carboxamide (DPC 423) by novel metabolic pathways. Characterization of unusual metabolites by liquid chromatography/mass spectrometry and NMR.
    Mutlib AE; Shockcor J; Chen SY; Espina RJ; Pinto DJ; Orwat MJ; Prakash SR; Gan LS
    Chem Res Toxicol; 2002 Jan; 15(1):48-62. PubMed ID: 11800597
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metabolism distribution and excretion of a matrix metalloproteinase-13 inhibitor, 4-[4-(4-fluorophenoxy)-benzenesulfonylamino]tetrahydropyran-4-carboxylic acid hydroxyamide (CP-544439), in rats and dogs: assessment of the metabolic profile of CP-544439 in plasma and urine of humans.
    Dalvie D; Cosker T; Boyden T; Zhou S; Schroeder C; Potchoiba MJ
    Drug Metab Dispos; 2008 Sep; 36(9):1869-83. PubMed ID: 18566038
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metabolism of dictamnine in liver microsomes from mouse, rat, dog, monkey, and human.
    Wang P; Zhao Y; Zhu Y; Sun J; Yerke A; Sang S; Yu Z
    J Pharm Biomed Anal; 2016 Feb; 119():166-74. PubMed ID: 26683990
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The exposure of highly toxic aconitine does not significantly impact the activity and expression of cytochrome P450 3A in rats determined by a novel ultra performance liquid chromatography-tandem mass spectrometric method of a specific probe buspirone.
    Zhu L; Yang X; Zhou J; Tang L; Xia B; Hu M; Zhou F; Liu Z
    Food Chem Toxicol; 2013 Jan; 51():396-403. PubMed ID: 23085095
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [In vitro metabolism of forscolin isolated from Coleus forskohlii].
    Zhang M; Meng ZY; Zhu XX; Dou GF
    Yao Xue Xue Bao; 2013 Mar; 48(3):383-9. PubMed ID: 23724652
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Species difference in stereoselective involvement of CYP3A in the mono-N-dealkylation of disopyramide.
    Zhang L; Fitzloff JF; Engel LC; Cook CS
    Xenobiotica; 2001 Feb; 31(2):73-83. PubMed ID: 11407536
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro metabolism of irosustat, a novel steroid sulfatase inhibitor: interspecies comparison, metabolite identification, and metabolic enzyme identification.
    Ventura V; Solà J; Celma C; Peraire C; Obach R
    Drug Metab Dispos; 2011 Jul; 39(7):1235-46. PubMed ID: 21464173
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro biotransformation of a novel antimalarial cysteine protease inhibitor in human liver microsomes.
    Zhang Y; Guo X; Lin ET; Benet LZ
    Pharmacology; 1999 Mar; 58(3):147-59. PubMed ID: 9925971
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Concurrent induction and mechanism-based inactivation of CYP3A4 by an L-valinamide derivative.
    Luo G; Lin J; Fiske WD; Dai R; Yang TJ; Kim S; Sinz M; LeCluyse E; Solon E; Brennan JM; Benedek IH; Jolley S; Gilbert D; Wang L; Lee FW; Gan LS
    Drug Metab Dispos; 2003 Sep; 31(9):1170-5. PubMed ID: 12920173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.